However, it is also possible that cryopreservation costs could increase as more sophisticated methods are developed and used. In addition, Alcor has traditionally eschewed profits in an effort to keep cryonics affordable. More traditional medical institutions might adopt higher prices to enhance profitability.

While higher prices might lead to lower adoption rates, there is the opposite possibility, that more sophisticated procedures would be trusted and recommended more by physicians. Also it seems plausible that a higher degree of profitability would lead to a better marketed product.